Stockreport

The Bull Case For Sarepta Therapeutics (SRPT) Could Change Following ESSENCE Trial Miss and FDA Discussions [Yahoo! Finance]

Sarepta Therapeutics, Inc.  (SRPT) 
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF 45 and VYONDYS 53 did not meet the primary endpoint, though numerical trends favored the treatments and safety was comparable to placebo. Despite missing statistical s [Read more]